ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate

CAS No.
1188035-40-6
Chemical Name:
ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate
Synonyms
ethyl 4-(6-bromo-1H-benzimidazol-2-yl)benzoate;ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate;Benzoic acid, 4-(6-bromo-1H-benzimidazol-2-yl)-, ethyl ester
CBNumber:
CB92616653
Molecular Formula:
C16H13BrN2O2
Molecular Weight:
345.19
MDL Number:
MFCD11218450
MOL File:
1188035-40-6.mol

ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate Properties

Boiling point 512.1±56.0 °C(Predicted)
Density 1.494±0.06 g/cm3(Predicted)
pka 9.88±0.10(Predicted)

ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Matrix Scientific 189064 Ethyl 4-(5-bromo-1H-benzo[d]imidazol-2-yl)benzoate 1188035-40-6 500mg $1126 2021-12-16 Buy
Matrix Scientific 189064 Ethyl 4-(5-bromo-1H-benzo[d]imidazol-2-yl)benzoate 1188035-40-6 1g $1800 2021-12-16 Buy
Product number Packaging Price Buy
189064 500mg $1126 Buy
189064 1g $1800 Buy

ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate Preparation Products And Raw materials

Raw materials

Preparation Products

ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate Suppliers

Global( 1)Suppliers
Supplier Tel Email Country ProdList Advantage
Frontier Scientific, Inc. -- sales@frontiersci.com United States 6222 86
Supplier Advantage
Frontier Scientific, Inc. 86
ethyl 4-(5-broMo-1H-benzo[d]iMidazol-2-yl)benzoate ethyl 4-(6-bromo-1H-benzimidazol-2-yl)benzoate Benzoic acid, 4-(6-bromo-1H-benzimidazol-2-yl)-, ethyl ester 1188035-40-6
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept